| Net Cash Provided by (Used in) Operating Activities |
$922,293 |
USD |
-381% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$79,479 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$662,450 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
15,751,153 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$339,322 |
USD |
-227% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,832,133 |
USD |
-35% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$383,000 |
USD |
26% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,909,000 |
USD |
22% |
Q1 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$52,249 |
USD |
58% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$10,191,393 |
USD |
4.8% |
Q1 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$143,356 |
USD |
-0.4% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
$10,163,952 |
USD |
3% |
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$153,723 |
USD |
-3% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,526,000 |
USD |
21% |
Q1 2025 |
FY 2025 |